WATANABE Jun 渡部淳

Researcher Number	10452335
Affiliation (based on the past Project Information) *help	2010: 京都大学, 医学(系)研究科(研究院), 助教 2007 – 2009: Kyoto University, 医学研究科, 助教
Review Section/Research Field	Principal Investigator Urology Except Principal Investigator Urology / Applied pharmacology
Keywords	Principal Investigator 膀胱発癌 / 化学療法抵抗性 / 尿路上皮癌 / CXCL1 / galectin-7 / urinary bladder / TBP-2 / triptolide Except Principal Investigator HERPUD1 / S100P … More / GADD45A / ATF3 / LASP1 / LASP-1 / PURA / 去勢抵抗性 / 前立腺癌 / PURA LASP-1 / マトリックスリモデリング / CCL2 / MMP-2/9 / JunB / VHL / 抗血管新生療法 / マトリックス・リモデリング / 腎細胞癌 Less

The investigation of individual anti-angiogenic therapy focused on the control mechanism of matrix remodeling in renal cell carcinoma
- Principal Investigator
  
  KAMBA Tomomi
- Project Period (FY)
  2009 – 2011
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Applied pharmacology
- Research Institution
  Kyoto University
尿路上皮癌初期発生過程における治療抵抗性獲得機序の解明Principal Investigator
- Principal Investigator
  
  渡部淳
- Project Period (FY)
  2009 – 2011
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  Kyoto University
Exploration of a new molecular target of hormone refractory prostate cancer based on nuclear matrix proteins
- Principal Investigator
  
  INOUE Takahiro
- Project Period (FY)
  2009 – 2011
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  Kyoto University
Mechanisms of accumulation of G1-S phase cell cycle regulating protein in bladder carcinogenesis for the development of novel intarvesical treatment modalities to bladder cancerPrincipal Investigator
- Principal Investigator
  
  WATANABE Jun
- Project Period (FY)
  2007 – 2008
- Research Category
  
  Grant-in-Aid for Young Scientists (Start-up)
- Research Field
  
  Urology
- Research Institution
  Kyoto University

All 2009 2008 2007

All Journal Article Presentation

[Journal Article] Dicoumarol enhances doxorubicin-induced cytotoxicity in p53 wild-type urothelial cancer cells throuah p38 activation.2009
- Author(s)
  Matsui Y, Watanabe J, Ding S, et al
- Journal Title
  
  BJU international 105
  
  Pages: 558-564
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21592042
[Journal Article] Development of a multiplex RNA urine test for the detection and stratification of transitional cell carcinoma of the bladder2008
- Author(s)
  Holyoake A, O'Sullivan P, Pollock R, Best T, Watanabe J, Kajita Y, Matsui Y, Ito M, Nishiyama H, Kerr N, da Silva Tately F, Cambridge L, Toro T, Ogawa O, Guilford P.
- Journal Title
  
  Clinical Cancer Research 14(3)
  
  Pages: 742-74
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19890113
[Journal Article] Cancer-specific enhancement of cisplatin-induced cytotoxicity with triptolide through an interaction of inactivated glycogen synthase kinase-3beta with p532008
- Author(s)
  Y Matsui, J Watanabe, M Ikegawa, T Kamoto, O Ogawa and H Nishiyama
- Journal Title
  
  Oncogene 27
  
  Pages: 4603-4614
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19890113
[Journal Article] Development of a multiplex RNA urine test for the detection and stratification of transitional cell carcinoma of the bladder2008
- Author(s)
  Holyoake A, O' Sullivan P, Pollock R, Best T, Watanabe J, Kajita Y, Matsui Y, Ito M, Nishiyama H, Kerr N, da Silva Tately F, Cambridge L, Toro T, Ogawa O, Guilford P.
- Journal Title
  
  Clinical Cancer Research 14(3)
  
  Pages: 742-749
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19890113
[Journal Article] Secreted CXCL1 is a potential mediator and marker of the tumor invasion of bladder cancer.2008
- Author(s)
  Kawanishi H, Matsui Y, Ito M, Watanabe J, Takahashi T, Nishizawa K, Nishiyama H, Kamoto T, Mikami Y, Tanaka Y, Jung G, Akiyama H, Nobumasa H, Guilford P, Reeve A, Okuno Y, Tsujimoto G, Nakamura E, Ogawa O.
- Journal Title
  
  Clinical Cancer Research 14(9)
  
  Pages: 2579-2587
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19890113
[Journal Article] Cancer-specific enhancement of cisplatin-induced cytotoxicity with triptolide through an interaction of inactivated glycogen synthase kinase-3beta with p53.2008
- Author(s)
  Y Matsui, J Watanabe, M Ikegawa, T Kamoto, O Ogawa, H Nishiyama
- Journal Title
  
  Oncogene 27
  
  Pages: 4603-4614
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19890113
[Journal Article] Secreted CXCL1 is a potential mediator and marker of the tumor invasion of bladder cancer2008
- Author(s)
  Kawanishi H, Matsui Y, Ito M, Watanabe J, Takahashi T, Nishizawa K, Nishiyama H, Kamoto T, Mikami Y, Tanaka Y, Jung G, Akiyama H, Nobumasa H, Guilford P, Reeve A, Okuno Y, Tsujimoto G, Nakamura E, Ogawa O.
- Journal Title
  
  Clinical Cancer Research 14(9)
  
  Pages: 742-749
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19890113
[Journal Article] Genetic analysis of multifocal urothelial cancers by array-based comparative genomic hybridisation,2007
- Author(s)
  kawanishi H, Takahashi T, Ito M, Matsui Y, Watanabe J, Ito N, Kamoto T, Kadowaki T, Tsujimoto G, Imoto I, Inazawa J, Nishiyama H, Ogawa O.
- Journal Title
  
  British Journal of cancer 97(2)
  
  Pages: 260-266
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19890113
[Presentation] Thioredoxin-binding protein 2 as a predictive factor for response to cisplatinum-based chemotherapy in bladder cancer2008
- Author(s)
  Koji Nishizawa, Yoshiyuki Matsui, Hiroyuki Nishiyama, Jun Watanabe, Yoichiro Kajita, Toshiyuki Kamoto, and Osamu Ogawa
- Organizer
  9th Asian Congress of Urology
- Place of Presentation
  New Delhi, India
- Year and Date
  2008-10-04
- Data Source
  KAKENHI-PROJECT-19890113
[Presentation] Thioredxin-binding protein 2 as a predictive factor for response to cisplatinum-based chemotherapy in bladde rcancer.2008
- Author(s)
  Koji Nishizawa, Yoshiyuki Matsui, Hiroyuki Nishiyama, Jun Watanabe, Yoichiro Kajita, Toshiyuki Kamoto, Osamu Ogawa
- Organizer
  9th Asian Congress of Urology
- Place of Presentation
  New Delhi, India
- Year and Date
  2008-10-04
- Data Source
  KAKENHI-PROJECT-19890113
[Presentation] 尿路上皮癌におけるtriptolideを用いた癌特異的p21target therapyに関する検討2008
- Author(s)
  松井喜之、西山博之、渡部淳、西澤恒二、梶田洋一郎、賀本敏行、小川修
- Organizer
  第17回泌尿器科分子細胞研究会
- Place of Presentation
  東京
- Year and Date
  2008-02-16
- Data Source
  KAKENHI-PROJECT-19890113
[Presentation] Thioredoxin-binding protein 2は膀胱癌におけるシスプラチン併用化学療法の耐性化因子である2008
- Author(s)
  西澤恒二、松井喜之、西山博之、渡部淳、梶田洋一郎、賀本敏行、小川修
- Organizer
  第67回日本癌学会学術総会
- Place of Presentation
  名古屋
- Year and Date
  2008-10-29
- Data Source
  KAKENHI-PROJECT-19890113

1. OGAWA Osamu (90260611)

# of Collaborated Projects: 3 results

# of Collaborated Products: 0 results
2. 兼松明弘 (90437202)

# of Collaborated Projects: 3 results

# of Collaborated Products: 0 results
3. 西山博之 (20324642)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
4. KAMBA Tomomi (20402836)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
5. INOUE Takahiro (80511881)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

WATANABE Jun 渡部 淳

Research Projects

Research Products

Co-Researchers

The investigation of individual anti-angiogenic therapy focused on the control mechanism of matrix remodeling in renal cell carcinoma

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

尿路上皮癌初期発生過程における治療抵抗性獲得機序の解明Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Exploration of a new molecular target of hormone refractory prostate cancer based on nuclear matrix proteins

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Mechanisms of accumulation of G1-S phase cell cycle regulating protein in bladder carcinogenesis for the development of novel intarvesical treatment modalities to bladder cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Dicoumarol enhances doxorubicin-induced cytotoxicity in p53 wild-type urothelial cancer cells throuah p38 activation.2009

Author(s)

Journal Title

Data Source

[Journal Article] Development of a multiplex RNA urine test for the detection and stratification of transitional cell carcinoma of the bladder2008

Author(s)

Journal Title

Data Source

[Journal Article] Cancer-specific enhancement of cisplatin-induced cytotoxicity with triptolide through an interaction of inactivated glycogen synthase kinase-3beta with p532008

Author(s)

Journal Title

Data Source

[Journal Article] Development of a multiplex RNA urine test for the detection and stratification of transitional cell carcinoma of the bladder2008

Author(s)

Journal Title

Data Source

[Journal Article] Secreted CXCL1 is a potential mediator and marker of the tumor invasion of bladder cancer.2008

Author(s)

Journal Title

Data Source

[Journal Article] Cancer-specific enhancement of cisplatin-induced cytotoxicity with triptolide through an interaction of inactivated glycogen synthase kinase-3beta with p53.2008

Author(s)

Journal Title

Data Source

[Journal Article] Secreted CXCL1 is a potential mediator and marker of the tumor invasion of bladder cancer2008

Author(s)

Journal Title

Data Source

[Journal Article] Genetic analysis of multifocal urothelial cancers by array-based comparative genomic hybridisation,2007

Author(s)

Journal Title

Data Source

[Presentation] Thioredoxin-binding protein 2 as a predictive factor for response to cisplatinum-based chemotherapy in bladder cancer2008

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] Thioredxin-binding protein 2 as a predictive factor for response to cisplatinum-based chemotherapy in bladde rcancer.2008

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] 尿路上皮癌におけるtriptolideを用いた癌特異的p21target therapyに関する検討2008

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] Thioredoxin-binding protein 2は膀胱癌におけるシスプラチン併用化学療法の耐性化因子である2008

Author(s)

WATANABE Jun 渡部淳